Giannotti G, Mottarlini F, Heinsbroek JA, Mandel MR, James MH, Peters J. Oxytocin and orexin systems bidirectionally regulate the ability of opioid cues to bias reward seeking. Transl Psychiatry. 2022 Oct 4;12(1):432. PubMed PMID: 36195606
Peters J. Mile high on heroin: Lessons on the opioid epidemic from the Mile High City. Bioessays. 2022 Jun;44(6):e2100297. PubMed PMID: 35357019
Kearns AM, Siemsen BM, Hopkins JL, Weber RA, Scofield MD, Peters J, Reichel CM. Chemogenetic inhibition of corticostriatal circuits reduces cued reinstatement of methamphetamine seeking. Addict Biol. 2021 Aug 25;:e13097. [Epub ahead of print] PubMed PMID: 34431593
Giannotti G, Gong S, Fayette N, Heinsbroek JA, Orfila JE, Herson PS, Ford CP, Peters J. Extinction blunts paraventricular thalamic contributions to heroin relapse. Cell Rep. 2021 Aug 24;36(8):109605. PubMed PMID: 34433067
Heinsbroek JA, Giannotti G, Mandel MR, Josey M, Aston-Jones G, James MH, Peters J. A common limiter circuit for opioid choice and relapse identified in a rodent addiction model. Nat Commun. 2021 Aug 9;12(1):4788. PubMed PMID: 34373454
Peters J, Olson DE. Engineering Safer Psychedelics for Treating Addiction. Neurosci Insights. 2021;16:26331055211033847. PubMed PMID: 34350400
Heinsbroek JA, De Vries TJ, Peters J. Glutamatergic Systems and Memory Mechanisms Underlying Opioid Addiction. Cold Spring Harb Perspect Med. 2021 Mar 1;11(3). PubMed PMID: 32341068
Giannotti G, Gong S, Fayette N, Heinsbroek JA, Orfila JE, Herson PS, Ford CP, Peters J. Extinction blunts paraventricular thalamic contributions to heroin relapse. Cell Rep. 2021 Aug 24;36(8):109605. PubMed PMID: 34433067
Heinsbroek JA, Giannotti G, Mandel MR, Josey M, Aston-Jones G, James MH, Peters J. A common limiter circuit for opioid choice and relapse identified in a rodent addiction model. Nat Commun. 2021 Aug 9;12(1):4788. PubMed PMID: 34373454
Cameron LP, Tombari RJ, Lu J, Pell AJ, Hurley ZQ, Ehinger Y, Vargas MV, McCarroll MN, Taylor JC, Myers-Turnbull D, Liu T, Yaghoobi B, Laskowski LJ, Anderson EI, Zhang G, Viswanathan J, Brown BM, Tjia M, Dunlap LE, Rabow ZT, Fiehn O, Wulff H, McCorvy JD, Lein PJ, Kokel D, Ron D, Peters J, Zuo Y, Olson DE. A non-hallucinogenic psychedelic analogue with therapeutic potential. Nature. 2021 Jan;589(7842):474-479. PubMed PMID: 33299186
Peters J, Olson DE. Engineering Safer Psychedelics for Treating Addiction. Neurosci Insights. 2021;16:26331055211033847. PubMed PMID: 34350400
Heinsbroek JA, De Vries TJ, Peters J. Glutamatergic Systems and Memory Mechanisms Underlying Opioid Addiction. Cold Spring Harb Perspect Med. 2020 May 27. [Epub ahead of print] PubMed PMID: 32341068
Vazquez M, Frazier JH, Reichel CM, Peters J. Acute ovarian hormone treatment in freely cycling female rats regulates distinct aspects of heroin seeking. Learn Mem. 2020 Jan;27(1):6-11. PubMed PMID: 31843977
Struik RF, De Vries TJ, Peters J. Detrimental Effects of a Retrieval-Extinction Procedure on Nicotine Seeking, but Not Cocaine Seeking. Front Behav Neurosci. 2019;13:243. PubMed PMID: 31680898
Cameron LP, Tombari RJ, Lu J, Pell AJ, Hurley ZQ, Ehinger Y, Vargas MV, McCarroll MN, Taylor JC, Myers-Turnbull D, Liu T, Yaghoobi B, Laskowski LJ, Anderson EI, Zhang G, Viswanathan J, Brown BM, Tjia M, Dunlap LE, Rabow ZT, Fiehn O, Wulff H, McCorvy JD, Lein PJ, Kokel D, Ron D, Peters J, Zuo Y, and Olson DE (in press) A Non-Hallucinogenic Psychedelic Analog with Therapeutic Potential. Nature.